Business
Endonovo Therapeutics Appoints Dr. Peter Novak to its Scientific Advisory Board
Endonovo Therapeutics Appoints Dr. Peter Novak to its Scientific Advisory Board.
About this update from Endonovo Therapeutics, Inc.
[{"type":"text","content":"\nWOODLAND HILLS, Calif., July 15, 2019 (GLOBE NEWSWIRE) -- via NetworkWire -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) (\"Endonovo\" or the \"Company\"), a commercial-stage developer of noninvasive Electroceutical™ therapeutic devices, today announces the appointment of Peter Novak, M.D., Ph.D., to its Scientific Advisory Board.\n Endonovo CEO Alan Collier stated, “The Endonovo team is delighted to welcome Dr. Novak to the Scientific Board. Peter’s experience will add significant value to our oversight as we transition to and advance our differentiated development programs in Electroceuticals™. We also welcome the insights of Dr. Novak, whose expertise in key areas relating to our programs will inform both our clinical and post-operative strategies.” “Electroceutical™ therapy is a fascinating new frontier, and Endonovo has assembled a pipeline that approaches compelling pathways from unique angles,” said Dr. Novak. “There is a major need for therapeutics that improve post-operative recuperation, so I am pleased to join a team that has connected novel science with patient need so clearly.” Background – Peter Novak, M.D. Peter Novak, M.D., Ph.D., is the director of the Autonomic Laboratory at the Department of Neurology, Brigham and Women’s Hospital in Boston, Massachusetts. He is a board-certified neurologist and a board-certified autonomic specialist. He is a member of the American Academy of Neurology, American Autonomic Society and the Autonomic Board of United Council for Neurologic Subspecialties. Dr. Novak graduated from medical school in Bratislava, Slovakia, and completed his neurology residency at Ohio State University. He also completed postdoctoral studies focusing on cardiovascular and autonomic research at Charles University (Prague) the University of Montreal, McGill University (Montreal) and the Mayo Clinic. He has special interests in autoimmune, small fiber and autonomic neuropathies, autoimmune, postural orthostatic tachycardia syndrome and multiple system atrophy. He has written over 70 papers and presented at numerous conferences. About Endonovo Therapeutics Endonovo Therapeutics, Inc. is a commercial-stage developer of noninvasive wearable Electroceuticals™ therapeutic devices. The Company's current portfolio of commercial and cli...